Boehringer Ingelheim marks landmark vaccination
Veterinarians and farmers across the globe have reached the landmark of protecting one billion pigs from the potentially devastating effects of Porcine Circovirus Disease (PCVD) using Boehringer Ingelheim Animal Health vaccine, Ingelvac CircoFlex.
The vaccine, which was launched by Boehringer Ingelheim Animal Health in 2006, contributes to securing the pigs’ health as well as providing healthier pork for consumption.
Based on yearly sales volumes (in comparison to all other vaccines in animal health), Ingelvac CircoFlex is the most successful animal vaccine of all time. The efficacy and safety of Ingelvac CircoFlex, which is a unique combination of Purified Circo Antigen (PCA) and the adjuvant platform ImpranFlex, have established the brand globally for vaccinating pigs against PCVD for several years.
PCVD is considered as being one of the most costly swine diseases – both from a herd health and an economic perspective. Prevention of PCVD and other diseases through vaccination reduces the need for antibiotics and leads to an improved quality of food for consumers worldwide.
Join 18,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the pigsector, three times a week.
